GPT Healthcare (GPTHEALTH)
Fast GrowerFairStock Score: 50/100 — MIXED
Score breakdown: P/E: 1/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹156.15 |
| Market Cap | ₹1,281.29 Cr |
| P/E Ratio | 27.11 |
| ROCE | 27.23% |
| ROE | 17.55% |
| Dividend Yield | 1.92% |
| Profit Growth | 65.72% |
| Debt/Equity | 0.34 |
| Sales Growth | 16.13% |
| Promoter Holding | 65.57% |
| 52-Week Range | ₹115 — ₹175 |
| Sector | Healthcare Services |
| Book Value | ₹32.84 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
GPT Healthcare is a decent business selling at a price that offers little room for error. The company earns a healthy 27.23% ROCE and 17.55% ROE, and debt/equity of 0.38 is manageable. Promoter holding of 65.57% aligns ownership with minority shareholders, and a 1.98% dividend yield softens the wait. Sales grew 17.56%, and the latest quarter brought in ₹120 crore of revenue. That is the good part.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer